Overfield series · Part 2 of 3 · 4 November 2026
What Would CFMG’s Management Fees and Alleged Cash Sweeps Actually Prove?
Money movement, service value and professional authority are separate questions. A serious investigation must connect them with documents rather than assume they are the same
A payment can be large without being unlawful. A management arrangement can be profitable without transferring medical authority. An accounting practice can be ordinary in one relationship and troubling in another, because the authorisation, the allocation of risk and the retained decision-making powers differ. This article sets out what the October 30 order actually reports about fees and “cash sweeps,” and the three tests that would have to be run before anyone could say what they mean.
What the public record says — exactly
Court’s account The October 30 order records that on 31 August 2026 plaintiffs told CFMG their financial expert wanted information about the management-services fees CFMG paid to Wellpath LLC, to assess whether the arrangement was “commensurate value for the services furnished” under Business and Professions Code § 650, and reports plaintiffs’ assertion that CFMG’s Rule 30(b)(6) witness, Blair Lukasik, testified that Wellpath took undocumented “cash sweeps” from CFMG’s account. The court was unpersuaded and granted CFMG’s protective order. It did not adopt plaintiffs’ description of the testimony.V01
Plaintiffs’ account of testimony The joint statement the court cites, ECF 95, sets out plaintiffs’ version in more detail, with transcript page numbers. According to plaintiffs, CFMG’s designee testified that:
- there is a bank account CFMG controls and bank accounts that Wellpath controls (Tr. 15–16);
- Wellpath provides management services, handling matters “simply administrative in nature, like accounting, finance, IT, HR” (Tr. 16);
- CFMG pays Wellpath 18 percent of its gross revenue — that is, before costs (Tr. 22–23);
- CFMG has operated at a loss in every year of the management agreement, and without the fee would show a profit and taxable income (Tr. 45–48);
- the fee was “recorded … on the books,” but “[t]here was no cash that was ever exchanged for those charges,” and Wellpath “never forced CFMG to pay that expense” (Tr. 24);
- Wellpath nonetheless takes some money in “cash sweeps,” in amounts not documented, and the witness could not say how much or how it is decided when sweeps occur (Tr. 24–27, 37–39, 44–45);
- unpaid fee amounts can be carried from one year into another (Tr. 41–42); and
- the witness did not know the cost of the services Wellpath provides and did not believe their value could feasibly be estimated (Tr. 48–50).
Plaintiffs illustrated the point with CFMG’s 2021 return. The revenue and net-income figures in that passage are redacted in the public filing; plaintiffs state that CFMG paid a $48 million management fee that year and argue that without it CFMG would have shown a substantial profit.V09
Defense position CFMG’s section does not contest those descriptions line by line. It says CFMG produced its 2021–2025 tax returns and “an unredacted Management Services Agreement (MSA), which includes the monthly payment percentage to Wellpath LLC,” that the requested material concerns non-party Wellpath rather than CFMG’s net worth, and that plaintiffs have no fee-value claim to pursue.V09
Not inspected This publication has not read the deposition transcript, its errata or its exhibits. Every phrase above is plaintiffs’ rendering of testimony in an advocacy document — accurate as a report of what plaintiffs told the court, not as a record of what the witness said in context. This publication does not reconstruct the redacted figures and does not adopt plaintiffs’ arithmetic.
Why the phrasing matters
“CFMG pays Wellpath 18 percent of its gross revenue” is, today, plaintiffs’ account of a corporate designee’s answer — not a finding, and not a document this publication has read. It is consistent with the 18 percent fee this investigation reported from the 2012 management agreement, and with CFMG’s statement that the produced agreement sets a monthly percentage. Consistency is not verification.
That record supports an attributed description of a dispute and a disciplined set of questions. It does not support a declaration that money was taken, concealed, improperly distributed or diverted from patient care.
1. Begin with the rule that favours legitimate management
Legal rule Section 650(a) makes it unlawful to pay or receive compensation “as compensation or inducement for referring patients.” Subdivision (b) then provides that consideration for services other than referrals, “based on a percentage of gross revenue or similar type of contractual arrangement shall not be unlawful if the consideration is commensurate with the value of the services furnished or with the fair rental value of any premises or equipment leased or provided by the recipient to the payer.”V11
Legal rule Epic Medical Management v. Paquette applied that text to a management agreement paid on a percentage of revenue and observed that subdivision (b) permits “precisely” such an arrangement — payment to a management company for management services based on a percentage of revenue — as long as the consideration is commensurate with the value of the services.V17
Analysis An article should not call a percentage management fee unlawful because it is computed against professional revenue. The serious questions are harder. What services are included, and which entity actually supplied them? Were some costs also charged separately? What methodology supports the compensation, and does it account for actual responsibilities, assets and risk? Are comparisons drawn between equivalent service bundles, or between unlike contracts? Those questions propose a method. They do not imply that cost alone determines lawful value, that a manager may not earn a return, or that CFMG paid an excessive fee.
Analysis Two points from the joint statement sharpen the value question without answering it. First, if — as plaintiffs recount — CFMG’s financial designee could neither state the cost of the services nor see a feasible way to value them, then the corporation’s own testimony offers no affirmative support for “commensurate value,” and the question remains open rather than answered either way. Second, plaintiffs’ assertion that CFMG is “required … by law” to conduct a valuation goes further than the text of § 650(b), which conditions lawfulness on commensurate value but does not, on its face, mandate a written valuation. A supportable valuation would be the obvious way to demonstrate compliance; its absence from this record is not proof that none exists.V09V11
2. A sweep is a mechanism, not a legal classification
Analysis Before any legal label attaches, a reviewer must distinguish at least five possible explanations for a transfer out of a professional corporation’s account to its manager:
- payment of an accrued management fee;
- reimbursement of an expense the manager paid on the practice’s behalf;
- repayment of a documented intercompany advance;
- a treasury-pooling transfer recorded as an enforceable receivable of the practice; or
- a distribution or other transfer requiring a different authority altogether.
These are hypotheses to test, not findings about any transaction alleged in Overfield, and more than one may apply over time. The same bank transfer must not be counted once as a fee and again as “extraction” without tracing the entries. A sweep is not automatically a loss of economic ownership if the transferring entity receives a valid, recoverable asset in return. Conversely, calling an entry an intercompany receivable does not answer who can collect it, when it is due, or what happens if the recipient cannot pay — questions that became concrete when the recipient entered Chapter 11.
Analysis Plaintiffs’ account, if accurate, describes three different events that are easily collapsed into one: an expense recognised on CFMG’s books; an amount owed that may accrue and carry forward; and cash actually moved, sometimes by sweep. A booked fee that is never paid can be an intercompany payable, a liability the creditor chooses not to enforce, or something else, depending on the instruments; a sweep can settle part of that payable, fund shared costs, or pool cash. Plaintiffs called the combination “fantastical.” It may instead be an ordinary feature of affiliated-group accounting — or it may reveal that the manager decides when the professional corporation’s cash leaves. The documents, not the adjectives, will tell which. The consequence for this investigation is narrower: a gross-revenue fee that is accrued, carried and selectively swept makes the question of who decides when to collect at least as important as the stated rate.
A meaningful transaction schedule would pair each movement’s date, amount, originating and receiving entity, bank authorisation, ledger classification, contractual basis and any repayment or offset — and would reconcile movements rather than add up outflows. No such schedule is established by any public order reviewed here.
3. Three distinct tests
For reporting purposes the investigation uses three tracks. They are an editorial method, not the elements of any cause of action, and not a test any court has adopted.
| Track | Question | Governing law |
|---|---|---|
| Value | Does the payment correspond to identified services or assets under an appropriate valuation approach? | § 650(b) — commensurate value; no referral component |
| Authority and accountability | Who authorised the transfer, under what instrument, with what reconciliation and what power to challenge or reverse it? | Contract, corporate governance and accounting records — this is what determines what the transfer is |
| Professional control | Does the arrangement confer power over a physician-reserved decision, directly or through an enforceable contractual right? | §§ 2052, 2400; Medical Board guidance; Epic’s “exercises or has retained the right” test |
Analysis An arrangement can pass one track and fail another. Reasonable compensation does not authorise prohibited control. Strong physician governance does not validate every accounting charge. The investigation must not let either argument do the work of both.V11V16V17
4. Liquidity deserves attention, not exaggeration
Analysis A practice may show positive accounting value while lacking ready cash. Another may participate in centralised cash management while holding a reliable contractual right to funds whenever needed. Those situations must be distinguished before anyone argues that treasury management compromises professional independence. The useful questions are specific: can the professional corporation meet its own obligations; who has final authority over protected decisions; what happens when a physician-approved expenditure is disputed; and is there an enforceable, workable process for reaching the funds?
A physician-reserved equipment choice and an administrator’s invoice processing are different things. A clinical recommendation subject to a non-licensee veto would raise a different issue from routine confirmation that a bill matches an approved purchase. The Medical Board’s guidance makes final protected authority central; it does not eliminate all financial constraints or turn every budget discussion into unlicensed practice.V16 Nothing in the orders reviewed shows that CFMG experienced a clinically harmful cash shortage or a financial veto.
5. Consolidation is not a corporate-practice clearance certificate
Court’s account The 2025 order accepted, for the punitive-damages inquiry, CFMG’s production of consolidated GAAP-audited financial statements, tax returns and other financial information, and recorded CFMG’s representation that its tax returns detail the total management fees paid each year. That is meaningful support for the adequacy of CFMG’s production in that dispute.V02
Analysis It does not answer different questions: who legally owns the professional shares, whether an intercompany claim is enforceable, what each service is worth, or who holds clinical authority. Equally, consolidation does not by itself prove that separate entities are alter egos. A publication that has not seen the full statements should not identify their consolidation basis, claim that an audit certified a fee’s fair value, or infer that an unproduced standalone ledger never existed. The proper next request is for the relevant records and their explanatory notes — not a declaration of what missing records must show.
6. Follow the chain of authority
Plaintiffs’ account of testimony The joint statement attributes to CFMG’s designee a description of one bank account CFMG controls and bank accounts Wellpath controls.V09 Analysis That is the right place to start, because control of an account is a power, not a balance. The questions are which accounts receive CFMG’s county-contract revenue; who holds signing and transfer authority over each; whether sweeps run from CFMG’s account under a standing mandate or by case-by-case instruction; and whether CFMG’s licensed decision-makers can stop or reverse them.
Analysis The best evidence would connect money to a power: a transfer provision, an approval matrix, a bank mandate, a financing condition, a default remedy or an owner-replacement mechanism. The next question is whether that power reaches a protected professional decision and whether any lawful exception applies. The California Attorney General’s March 2026 amicus brief in Art Center Holdings v. WCE CA Art argues — as an official litigation position, not a holding — that corporations “need not actually exercise control” over medical decision-making to violate the corporate-practice bar, and describes “captive” arrangements, in which a manager installs a friendly physician-owner and contracts for the right to replace that owner, as the relationship posing the greatest risk.V19
This inquiry must be capable of a finding favourable to the companies. Documented, revocable treasury agency; meaningful physician approval; independently supported fees; accessible funds; and a practical ability to change vendors would each rebut a claim of managerial domination. A verified arrangement letting a non-licensee use financial access as an enforceable veto over protected medical decisions would require analysis well beyond whether the annual statements show a profit. That is a conditional legal concern — not a description of CFMG’s arrangement.V17V18V16
7. The hypothesis matrix: what would prove it, what would clear it
| Hypothesis | Records that would test it | Evidence that would rebut it |
|---|---|---|
| The fee pays for more than legitimate non-referral services | Operative management agreement and amendments; service schedules; invoices; cost allocations; valuation support; separately billed contracts | Independent valuation of comparable services and risk; no referral component; no duplicate charges; physician approval |
| Transfers give the manager unilateral power over the practice’s resources | Bank mandates; treasury agreement; approval limits; ledger entries; reconciliations; intercompany receivables and loan terms | Revocable authority; documented reconciliation; enforceable access to funds; ordinary fee settlement; repayment of valid debt |
| Financial powers reach physician-reserved decisions | Delegations; budget-exception process; clinical approval matrices; contemporaneous requests and responses; default remedies | Licensed decision-makers retain final authority; administrators implement rather than override; disputes resolved through a lawful process |
None of these hypotheses is established by the public orders. The middle column lists targets for lawful access — not material that a journalist or private complainant is entitled to compel, and not material this publication has obtained.
8. What this article does not claim
It does not claim a court-verified fee percentage, a sweep amount, an unauthorised transfer, a deprivation of clinical funds, or a § 650 violation. It does not draw False Claims Act, Anti-Kickback Statute, insurance-fraud, tax or fraudulent-transfer conclusions from the existence of a management fee or an alleged sweep; each would require distinct facts and elements. And it does not treat the 18 percent figure in plaintiffs’ account as proven, or merge it with the investigation’s historical discussion of the 2012 agreement — that figure keeps its own source and period in Article 016.
The public-interest standard
The investigation should neither sensationalise the phrase “cash sweep” nor dismiss the questions it raises. It should ask for classification, authorisation, accounting and consequence, while keeping disputed testimony separate from adjudicated findings.
The pivotal issue is not simply where money moved. It is what legal authority accompanied the movement — and whether that authority preserved or displaced the physician’s protected role.
Continue: Part 1 — discovery is not clearance · Part 3 — who can say no · the evidence ledger · Article 017 — deficit funding and security interests
Source register
- V01Overfield v. County of El Dorado et al. (caption as in the order), No. 2:24-cv-0199 TLN AC (E.D. Cal.), ECF 96 — order granting CFMG’s motion for a protective order
- V02Overfield v. Wellpath Community Care, LLC et al., ECF 72 — order denying plaintiffs’ motion to compel (ECF 69)
- V09Overfield, ECF 95 — Joint Discovery Statement re: Discovery Dispute (public redacted filing)
- V11California Business and Professions Code § 650 — (a) referral compensation; (b) percentage-based compensation for non-referral services
- V16Medical Board of California — Practice Information: Corporate Practice of Medicine (Bus. & Prof. Code §§ 2052, 2400)
- V17Epic Medical Management, LLC v. Paquette (2015) 244 Cal.App.4th 504 (No. B261541)
- V18People ex rel. Allstate Ins. Co. v. Discovery Radiology Physicians, P.C. (2023) 94 Cal.App.5th 521 (No. B315264)
- V19California Attorney General, amicus curiae brief in support of neither party, Art Center Holdings, Inc. v. WCE CA Art, LLC, No. B338625 (Cal. Ct. App., 2d Dist., Div. 3)